Literature DB >> 18301873

[Diabetic cardiomyopathy--a type of coronary artery disease?].

B Stratmann1, I Stork, D Tschoepe.   

Abstract

Diabetic cardiomyopathy is a myocardial disease caused by diabetes mellitus unrelated to vascular and valvular pathology or systemic arterial hypertension. Clinical and experimental studies have shown that diabetes mellitus causes myocardial hypertrophy, apoptosis and necrosis, and increases interstitial tissue. The pathophysiology of diabetic cardiomyopathy is incompletely understood and several mechanistical approaches are under debate. Metabolic impairments like hyperglycemia, hyperlipidemia, hyperinsulinemia, and alterations in the cardiac metabolism lead to structural and functional changes which show cellular effects leading to increased oxidative stress, interstitial fibrosis, myocyte death, and disturbances in ion transport and homeostasis. Diastolic dysfunction which consecutively results in systolic dysfunction with increased left ventricular volume and reduced ejection fraction is an early diagnostic parameter. Treatment of diabetic cardiomyopathy does not differ from myocardiopathies of other etiologies and therefore has to follow the appropriate guidelines. Early intervention to reverse metabolic toxicity is the most effective method of prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18301873     DOI: 10.1007/s00108-008-2047-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  Myocyte apoptosis and heart failure.

Authors:  P Anversa
Journal:  Eur Heart J       Date:  1998-03       Impact factor: 29.983

3.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

4.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart.

Authors:  H Nakayama; T Morozumi; S Nanto; T Shimonagata; T Ohara; Y Takano; J Kotani; T Watanabe; M Fujita; M Nishio; H Kusuoka; M Hori; S Nagata
Journal:  Jpn Circ J       Date:  2001-09

6.  Association of proinsulin and insulin resistance with coronary artery disease in non-diabetic south Indian men.

Authors:  C Snehalatha; A Ramachandran; I Saltyamurthy; K Satyavani; S Sivasankari; J Misra; V Viswanathan
Journal:  Diabet Med       Date:  2001-09       Impact factor: 4.359

Review 7.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Zhi You Fang; Johannes B Prins; Thomas H Marwick
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

8.  Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus.

Authors:  S Nunoda; A Genda; N Sugihara; A Nakayama; S Mizuno; R Takeda
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo.

Authors:  R R Russell; R Yin; M J Caplan; X Hu; J Ren; G I Shulman; A J Sinusas; L H Young
Journal:  Circulation       Date:  1998-11-17       Impact factor: 29.690

View more
  3 in total

1.  Diabetic cardiomyopathy--fact or fiction?

Authors:  B Maisch; P Alter; S Pankuweit
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

2.  Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment.

Authors:  Cimen Karasu
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

Review 3.  Shifting the disease management paradigm from glucose: what are the pros?

Authors:  Alin Stirban; Diethelm Tschoepe; Bernd Stratmann
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.